EACR - European Association for Cancer Research
@helloeacr.bsky.social
The European Association for Cancer Research has 14,000+ members. Our aim? Advancing cancer research 🥼🔬🌍 #KeepResearchCurious
www.eacr.org
www.eacr.org
Got some down time before the New Year? Catch up with The Cancer Researcher Podcast, where we dive into the inspiring and challenging world of being a cancer researcher.
Explore topics from navigating imposter syndrome to mastering scientific communication: magazine.eacr.org/podcast/
Explore topics from navigating imposter syndrome to mastering scientific communication: magazine.eacr.org/podcast/
December 26, 2025 at 12:01 PM
Got some down time before the New Year? Catch up with The Cancer Researcher Podcast, where we dive into the inspiring and challenging world of being a cancer researcher.
Explore topics from navigating imposter syndrome to mastering scientific communication: magazine.eacr.org/podcast/
Explore topics from navigating imposter syndrome to mastering scientific communication: magazine.eacr.org/podcast/
The EACR team are taking a break over the festive period, returning in the new year on Monday 05 January. You will continue to see posts from us, but please note that inboxes will not be monitored.
We wish happy holidays to all who celebrate! ☺️
We wish happy holidays to all who celebrate! ☺️
December 22, 2025 at 9:32 AM
The EACR team are taking a break over the festive period, returning in the new year on Monday 05 January. You will continue to see posts from us, but please note that inboxes will not be monitored.
We wish happy holidays to all who celebrate! ☺️
We wish happy holidays to all who celebrate! ☺️
We’ve pulled together the key takeaways from our recent Patient Involvement in Cancer Research event, from powerful patient perspectives to practical guidance for researchers on meaningful patient involvement.
Catch up on the highlights:
magazine.eacr.org/highlights-f...
Catch up on the highlights:
magazine.eacr.org/highlights-f...
December 19, 2025 at 3:31 PM
We’ve pulled together the key takeaways from our recent Patient Involvement in Cancer Research event, from powerful patient perspectives to practical guidance for researchers on meaningful patient involvement.
Catch up on the highlights:
magazine.eacr.org/highlights-f...
Catch up on the highlights:
magazine.eacr.org/highlights-f...
You don't have long left to register for Signalling Circuits in Cancer! Don't miss your opportunity to hear the latest research in this area from renowned speakers.
📅 10-11 February
Register by 19 January: eacr.org/conference/s...
📅 10-11 February
Register by 19 January: eacr.org/conference/s...
December 19, 2025 at 9:02 AM
You don't have long left to register for Signalling Circuits in Cancer! Don't miss your opportunity to hear the latest research in this area from renowned speakers.
📅 10-11 February
Register by 19 January: eacr.org/conference/s...
📅 10-11 February
Register by 19 January: eacr.org/conference/s...
Abstract submission is OPEN for the #EACR2026 Annual Congress, and registration opens in the new year 🌍💫
Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts
Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts
December 17, 2025 at 9:01 AM
Abstract submission is OPEN for the #EACR2026 Annual Congress, and registration opens in the new year 🌍💫
Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts
Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts
Happening tomorrow! Ido Amit will discuss how recent single cell genomic studies are changing our perspective of various immune related pathologies from cancer to autoimmune disease and neurodegeneration.
📅 16 Dec at 14:00 CET
📅 16 Dec at 14:00 CET
Welcome! You are invited to join a webinar: Meet the Expert with Prof Ido Amit: “Leveraging single cell technologies to engineer the immune system” - The Pezcoller Foundation-EACR Translational Cancer Researcher Award 2025. After registering, you will receive a confirmation email about joining the webinar.
The European Association for Cancer Research invites you to join this free virtual event, exclusively available to EACR members with Prof Ido Amit, hosted by Andrew Binns (EACR Membership Manager) Format:...
us02web.zoom.us
December 15, 2025 at 9:01 AM
Happening tomorrow! Ido Amit will discuss how recent single cell genomic studies are changing our perspective of various immune related pathologies from cancer to autoimmune disease and neurodegeneration.
📅 16 Dec at 14:00 CET
📅 16 Dec at 14:00 CET
Submit your abstract for our virtual Next Generation Immunotherapies conference for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation.
Don't miss the 12 January deadline: eacr.org/conference/n...
Don't miss the 12 January deadline: eacr.org/conference/n...
December 12, 2025 at 9:01 AM
Submit your abstract for our virtual Next Generation Immunotherapies conference for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation.
Don't miss the 12 January deadline: eacr.org/conference/n...
Don't miss the 12 January deadline: eacr.org/conference/n...
Europe has the talent, ideas and networks to beat cancer. In a recent Nature Cancer article, EACR & EACS leaders urge EU investment in research to turn discoveries into real patient benefits.
@johannajoyce.bsky.social #KeepResearchCurious
magazine.eacr.org/european-can...
@johannajoyce.bsky.social #KeepResearchCurious
magazine.eacr.org/european-can...
December 11, 2025 at 10:00 AM
Europe has the talent, ideas and networks to beat cancer. In a recent Nature Cancer article, EACR & EACS leaders urge EU investment in research to turn discoveries into real patient benefits.
@johannajoyce.bsky.social #KeepResearchCurious
magazine.eacr.org/european-can...
@johannajoyce.bsky.social #KeepResearchCurious
magazine.eacr.org/european-can...
What's most exciting in cancer research right now?
We've selected ten remarkable and influential recent papers, offering a concise summary of the cutting-edge advances taking place in the field: magazine.eacr.org/highlights-i...
We've selected ten remarkable and influential recent papers, offering a concise summary of the cutting-edge advances taking place in the field: magazine.eacr.org/highlights-i...
Highlights in Cancer Research: December 2025 - The Cancer Researcher
The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research.
magazine.eacr.org
December 11, 2025 at 8:00 AM
What's most exciting in cancer research right now?
We've selected ten remarkable and influential recent papers, offering a concise summary of the cutting-edge advances taking place in the field: magazine.eacr.org/highlights-i...
We've selected ten remarkable and influential recent papers, offering a concise summary of the cutting-edge advances taking place in the field: magazine.eacr.org/highlights-i...
We are delighted to announce the 2026 winner of the Pezcoller-EACR Translational Cancer Researcher Award is Samra Turajlic at @cruk-mi.bsky.social 👏
She will deliver her Award Lecture at #EACR2026 in Budapest.
eacr.org/pezcoller-fo...
She will deliver her Award Lecture at #EACR2026 in Budapest.
eacr.org/pezcoller-fo...
December 10, 2025 at 9:05 AM
We are delighted to announce the 2026 winner of the Pezcoller-EACR Translational Cancer Researcher Award is Samra Turajlic at @cruk-mi.bsky.social 👏
She will deliver her Award Lecture at #EACR2026 in Budapest.
eacr.org/pezcoller-fo...
She will deliver her Award Lecture at #EACR2026 in Budapest.
eacr.org/pezcoller-fo...
Please join us in congratulating our 2026 winner of the Pezcoller-EACR Women in Cancer Research Award, Ayelet Erez (Weizmann Institute of Science, Israel) 👏
She will deliver her Award Lecture at the #EACR2026 Congress in Budapest next year.
eacr.org/pezcoller-fo...
She will deliver her Award Lecture at the #EACR2026 Congress in Budapest next year.
eacr.org/pezcoller-fo...
December 10, 2025 at 9:00 AM
Please join us in congratulating our 2026 winner of the Pezcoller-EACR Women in Cancer Research Award, Ayelet Erez (Weizmann Institute of Science, Israel) 👏
She will deliver her Award Lecture at the #EACR2026 Congress in Budapest next year.
eacr.org/pezcoller-fo...
She will deliver her Award Lecture at the #EACR2026 Congress in Budapest next year.
eacr.org/pezcoller-fo...
Our new podcast episode explores a fascinating research paper on the impact of high-fat diets on tumour growth, by Dr Hannah Prendeville and Dr Britta Kunkemoeller.
Listen or read the transcript:
Listen or read the transcript:
Research Focus: How Dietary Fats Shape Immune Defenses Against Cancer - Episode 27 of The Cancer Researcher Podcast - The Cancer Researcher
What you eat – specifically the type of fat – might matter for how well your immune system can fight cancer under conditions of obesity. In this episode of The Cancer Researcher Podcast, we discuss…
magazine.eacr.org
December 9, 2025 at 8:30 AM
Our new podcast episode explores a fascinating research paper on the impact of high-fat diets on tumour growth, by Dr Hannah Prendeville and Dr Britta Kunkemoeller.
Listen or read the transcript:
Listen or read the transcript:
Reposted by EACR - European Association for Cancer Research
🤝 In conjunction with the recent @helloeacr.bsky.social conference on #CancerNeuroscience we have an active call for papers!
📩 Submit your latest Research Article, Short Report or Method in the field of #BrainTumours #CNStumours #NeuroOncology
👉 More details buff.ly/OfzaVDe
📩 Submit your latest Research Article, Short Report or Method in the field of #BrainTumours #CNStumours #NeuroOncology
👉 More details buff.ly/OfzaVDe
December 4, 2025 at 9:01 AM
🤝 In conjunction with the recent @helloeacr.bsky.social conference on #CancerNeuroscience we have an active call for papers!
📩 Submit your latest Research Article, Short Report or Method in the field of #BrainTumours #CNStumours #NeuroOncology
👉 More details buff.ly/OfzaVDe
📩 Submit your latest Research Article, Short Report or Method in the field of #BrainTumours #CNStumours #NeuroOncology
👉 More details buff.ly/OfzaVDe
We're celebrating the crucial role of curiosity-driven cancer research in driving life-saving developments 🤩🙌
Learn more about the EACR's campaign: magazine.eacr.org/keepresearch...
Learn more about the EACR's campaign: magazine.eacr.org/keepresearch...
December 8, 2025 at 1:50 PM
We're celebrating the crucial role of curiosity-driven cancer research in driving life-saving developments 🤩🙌
Learn more about the EACR's campaign: magazine.eacr.org/keepresearch...
Learn more about the EACR's campaign: magazine.eacr.org/keepresearch...
Exciting news, cancer researchers - abstract submission is now OPEN for the #EACR2026 Annual Congress! 🌍💫
Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts
Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts
December 8, 2025 at 11:47 AM
Exciting news, cancer researchers - abstract submission is now OPEN for the #EACR2026 Annual Congress! 🌍💫
Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts
Submit your abstract for the chance to present your research internationally: 2026.eacr.org/abstracts
Watch our recent webinar hosted in collaboration with the Young European Hematology Association (yEHA) and the Young European Federation of Immunological Societies (yEFIS): ‘CAR T-cells for the treatment of hematological malignancies & solid tumours’:
VIDEO | CAR T-cells for the treatment of hematological malignancies & solid tumours - The Cancer Researcher
CAR T-cells for the treatment of hematological malignancies & solid tumours
magazine.eacr.org
December 3, 2025 at 9:01 AM
Watch our recent webinar hosted in collaboration with the Young European Hematology Association (yEHA) and the Young European Federation of Immunological Societies (yEFIS): ‘CAR T-cells for the treatment of hematological malignancies & solid tumours’:
In our Meet the Expert Webinar, exclusive to EACR members, Ido Amit will discuss how recent single cell genomic studies are changing our perspective of various immune related pathologies from cancer to autoimmune disease and neurodegeneration.
📅 16 Dec at 14:00 CET
us02web.zoom.us/webinar/regi...
📅 16 Dec at 14:00 CET
us02web.zoom.us/webinar/regi...
December 1, 2025 at 9:01 AM
In our Meet the Expert Webinar, exclusive to EACR members, Ido Amit will discuss how recent single cell genomic studies are changing our perspective of various immune related pathologies from cancer to autoimmune disease and neurodegeneration.
📅 16 Dec at 14:00 CET
us02web.zoom.us/webinar/regi...
📅 16 Dec at 14:00 CET
us02web.zoom.us/webinar/regi...
Watch our recent joint EACR and Bio-Rad webinar discussing recent development work with two new assay formats that provide coverage of 11 variants commonly found in endocrine therapy-resistant HR+, HER2- metastatic breast cancer patients.
Watch here:
Watch here:
VIDEO | Highly Sensitive and Specific Multiplexed Detection of Actionable Variants in EGFR, KRAS, BRAF, and ESR1 using ddPLEX Chemistry and the QX600 Droplet Digital PCR System - The Cancer Researcher
Hear about recent development work with two new assay formats that provide coverage of 11 variants commonly found in endocrine therapy-resistant HR+, HER2- metastatic breast cancer patients.
magazine.eacr.org
November 28, 2025 at 9:30 AM
Watch our recent joint EACR and Bio-Rad webinar discussing recent development work with two new assay formats that provide coverage of 11 variants commonly found in endocrine therapy-resistant HR+, HER2- metastatic breast cancer patients.
Watch here:
Watch here:
Reposted by EACR - European Association for Cancer Research
Join us for our upcoming webinar, Exploring the tumour immune landscape: Spatial and functional insights, with two excellent speakers Dr. Camilla Englom and Dr. Heidi Haikala in partnership with @helloeacr.bsky.social. Register here: https://bit.ly/4ixlhhy
November 27, 2025 at 9:48 AM
Join us for our upcoming webinar, Exploring the tumour immune landscape: Spatial and functional insights, with two excellent speakers Dr. Camilla Englom and Dr. Heidi Haikala in partnership with @helloeacr.bsky.social. Register here: https://bit.ly/4ixlhhy
"Pipettes won't help you here" - an EACR member's take on why basic familiarity with computational tools and data analysis is becoming essential, especially for early-career researchers working in cancer biology:
Why Early-Career Cancer Researchers Need to Embrace Bioinformatics - The Cancer Researcher
A practical take on why basic familiarity with computational tools and data analysis is becoming essential, especially for early-career researchers working in cancer biology.
magazine.eacr.org
November 27, 2025 at 9:30 AM
"Pipettes won't help you here" - an EACR member's take on why basic familiarity with computational tools and data analysis is becoming essential, especially for early-career researchers working in cancer biology:
Join our free webinar with @10xgenomics.bsky.social where we will discuss spatially resolving antigen receptors in tumour tissue, and ex vivo modeling of the tumour immune microenvironment in lung cancer.
📅 04 Dec 15:00 CET
us02web.zoom.us/webinar/regi...
📅 04 Dec 15:00 CET
us02web.zoom.us/webinar/regi...
November 26, 2025 at 9:01 AM
Join our free webinar with @10xgenomics.bsky.social where we will discuss spatially resolving antigen receptors in tumour tissue, and ex vivo modeling of the tumour immune microenvironment in lung cancer.
📅 04 Dec 15:00 CET
us02web.zoom.us/webinar/regi...
📅 04 Dec 15:00 CET
us02web.zoom.us/webinar/regi...
EACR Board members and other key opinion leaders author regular EACR Viewpoint articles in our affiliated journal, @moloncology.bsky.social
'The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies': febs.onlinelibrary.wiley.com/doi/10.1002/...
'The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies': febs.onlinelibrary.wiley.com/doi/10.1002/...
November 25, 2025 at 9:01 AM
EACR Board members and other key opinion leaders author regular EACR Viewpoint articles in our affiliated journal, @moloncology.bsky.social
'The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies': febs.onlinelibrary.wiley.com/doi/10.1002/...
'The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies': febs.onlinelibrary.wiley.com/doi/10.1002/...
Ana Baião expanded her PhD experience at KU Leuven thanks to an EACR Travel Fellowship, gaining hands-on skills with patient-derived colorectal cancer organoids, advanced co-culture systems, and drug response testing.
Read more about her experience:
Read more about her experience:
"A combination of professional growth and personal discovery": Ana Baião's EACR Travel Fellowship - The Cancer Researcher
Ana Baião's EACR Travel Fellowship
magazine.eacr.org
November 24, 2025 at 9:01 AM
Ana Baião expanded her PhD experience at KU Leuven thanks to an EACR Travel Fellowship, gaining hands-on skills with patient-derived colorectal cancer organoids, advanced co-culture systems, and drug response testing.
Read more about her experience:
Read more about her experience:
Reposted by EACR - European Association for Cancer Research
Our clinical partner @manchester.ac.uk is hosting an event on 12-13 March 2026, bringing together researchers, clinicians, and patient advocates to share the latest advances in melanoma research and explore ways to improve patient outcomes.
Learn more: sites.manchester.ac.uk/from-lab-to-...
Learn more: sites.manchester.ac.uk/from-lab-to-...
November 21, 2025 at 8:30 AM
Our clinical partner @manchester.ac.uk is hosting an event on 12-13 March 2026, bringing together researchers, clinicians, and patient advocates to share the latest advances in melanoma research and explore ways to improve patient outcomes.
Learn more: sites.manchester.ac.uk/from-lab-to-...
Learn more: sites.manchester.ac.uk/from-lab-to-...
You have until 15 December to register for our upcoming virtual conference! We will explore a seemingly paradoxical approach to cancer therapy, based on the deliberate hyper-activation of cancer-relevant signalling pathways.
Register from €60: eacr.org/conference/o...
Register from €60: eacr.org/conference/o...
November 21, 2025 at 9:01 AM
You have until 15 December to register for our upcoming virtual conference! We will explore a seemingly paradoxical approach to cancer therapy, based on the deliberate hyper-activation of cancer-relevant signalling pathways.
Register from €60: eacr.org/conference/o...
Register from €60: eacr.org/conference/o...